{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:12:05Z","timestamp":1781791925326,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:00:00Z","timestamp":1559865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5770-6","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T13:02:44Z","timestamp":1559912564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-9556","authenticated-orcid":false,"given":"Willem Jan","family":"van Weelden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine Eldevik","family":"Fasmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild L.","family":"Tangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Abbink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antionius E.","family":"van Herwaarden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Krakstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F. A. G.","family":"Massuger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingfrid S.","family":"Haldorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M. A.","family":"Pijnenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"5770_CR1","unstructured":"Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 11. Lyon. France: International Agency for Research on Cancer; 2013."},{"issue":"3","key":"5770_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1053>3.0.CO;2-T","volume":"91","author":"A Bergstrom","year":"2001","unstructured":"Bergstrom A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer. 2001;91(3):421\u201330.","journal-title":"Int J Cancer"},{"key":"5770_CR3","first-page":"107","volume":"208","author":"E Shaw","year":"2016","unstructured":"Shaw E, Farris M, McNeil J, Friedenreich C. Obesity and endometrial Cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches Sur le cancer. 2016;208:107\u201336.","journal-title":"Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches Sur le cancer"},{"issue":"18","key":"5770_CR4","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/cncr.30094","volume":"122","author":"JN McAlpine","year":"2016","unstructured":"McAlpine JN, Temkin SM, Mackay HJ. Endometrial cancer: not your grandmother's cancer. Cancer. 2016;122(18):2787\u201398.","journal-title":"Cancer."},{"issue":"2","key":"5770_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ejogrb.2012.10.028","volume":"166","author":"D Boll","year":"2013","unstructured":"Boll D, Karim-Kos HE, Verhoeven RH, Burger CW, Coebergh JW, Van de poll-Franse LV, et al. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in the Netherlands: a population based study. Eur J Obstet Gynecol Reprod Biol. 2013;166(2):209\u201314.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"5770_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/jnci\/djx214","volume":"110","author":"J Lortet-Tieulent","year":"2018","unstructured":"Lortet-Tieulent J, Ferlay J, Bray F, Jemal A. International patterns and trends in endometrial Cancer incidence, 1978-2013. J Natl Cancer Inst. 2018;110(4):354\u201361.","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"5770_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","volume":"15","author":"AG Renehan","year":"2015","unstructured":"Renehan AG, Zwahlen M, Egger M. Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer. 2015;15(8):484\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"5770_CR8","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531\u201343.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"5770_CR9","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/JME-15-0310","volume":"57","author":"H Zhao","year":"2016","unstructured":"Zhao H, Zhou L, Shangguan AJ, Bulun SE. Aromatase expression and regulation in breast and endometrial cancer. J Mol Endocrinol. 2016;57(1):R19\u201333.","journal-title":"J Mol Endocrinol"},{"issue":"1","key":"5770_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1079\/PNS200068","volume":"60","author":"TJ Key","year":"2001","unstructured":"Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc. 2001;60(1):81\u20139.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"5770_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10\u20137.","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"5770_CR12","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.ijgo.2015.06.005","volume":"131","author":"F Amant","year":"2015","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2015;131(Suppl 2):S96\u2013104.","journal-title":"Int J Gynaecol Obstet"},{"issue":"20","key":"5770_CR13","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors. J Clin Oncol. 2013;31(20):2607\u201318.","journal-title":"J Clin Oncol"},{"issue":"4","key":"5770_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1210\/er.2011-1015","volume":"33","author":"M Dalamaga","year":"2012","unstructured":"Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33(4):547\u201394.","journal-title":"Endocr Rev"},{"issue":"12","key":"5770_CR15","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1210\/jc.2017-01474","volume":"102","author":"N Hetemaki","year":"2017","unstructured":"Hetemaki N, Savolainen-Peltonen H, Tikkanen MJ, Wang F, Paatela H, Hamalainen E, et al. Estrogen metabolism in abdominal subcutaneous and visceral adipose tissue in postmenopausal women. J Clin Endocrinol Metab. 2017;102(12):4588\u201395.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5770_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1530\/EJE-15-0831","volume":"174","author":"H Paatela","year":"2016","unstructured":"Paatela H, Wang F, Vihma V, Savolainen-Peltonen H, Mikkola TS, Turpeinen U, et al. Steroid sulfatase activity in subcutaneous and visceral adipose tissue: a comparison between pre- and postmenopausal women. Eur J Endocrinol. 2016;174(2):167\u201375.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"5770_CR17","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1210\/jc.2010-2648","volume":"95","author":"J Lepine","year":"2010","unstructured":"Lepine J, Audet-Walsh E, Gregoire J, Tetu B, Plante M, Menard V, et al. Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metab. 2010;95(6):2689\u201398.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"5770_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.ijo.0803454","volume":"31","author":"P Maurovich-Horvat","year":"2007","unstructured":"Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond). 2007;31(3):500\u20136.","journal-title":"Int J Obes (Lond)"},{"issue":"62","key":"5770_CR19","doi-asserted-by":"publisher","first-page":"105184","DOI":"10.18632\/oncotarget.21917","volume":"8","author":"KK Mauland","year":"2017","unstructured":"Mauland KK, Eng O, Ytre-Hauge S, Tangen IL, Berg A, Salvesen HB, et al. High visceral fat percentage is associated with poor outcome in endometrial cancer. Oncotarget. 2017;8(62):105184\u201395.","journal-title":"Oncotarget."},{"key":"5770_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12885-016-2230-4","volume":"16","author":"S Ye","year":"2016","unstructured":"Ye S, Wen H, Jiang Z, Wu X. The effect of visceral obesity on clinicopathological features in patients with endometrial cancer: a retrospective analysis of 200 Chinese patients. BMC Cancer. 2016;16:209.","journal-title":"BMC Cancer"},{"issue":"1","key":"5770_CR21","first-page":"65","volume":"26","author":"K Nakamura","year":"2011","unstructured":"Nakamura K, Hongo A, Kodama J, Hiramatsu Y. Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer. Oncol Rep. 2011;26(1):65\u201371.","journal-title":"Oncol Rep"},{"key":"5770_CR22","unstructured":"Gynaecologie WO. Dutch Guideline Endometrial carcinoma. 2011."},{"issue":"2","key":"5770_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"5770_CR24","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Ter Horst","year":"2016","unstructured":"Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, et al. Host and environmental factors influencing individual human cytokine responses. Cell. 2016;167(4):1111\u201324 e13.","journal-title":"Cell."},{"issue":"12","key":"5770_CR25","first-page":"614","volume":"44","author":"YH Chan","year":"2003","unstructured":"Chan YH. Biostatistics 104: correlational analysis. Singap Med J. 2003;44(12):614\u20139.","journal-title":"Singap Med J"},{"issue":"12","key":"5770_CR26","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/S0196-0644(05)82622-8","volume":"19","author":"ML Gaddis","year":"1990","unstructured":"Gaddis ML, Gaddis GM. Introduction to biostatistics: part 6, correlation and regression. Ann Emerg Med. 1990;19(12):1462\u20138.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"5770_CR27","first-page":"650","volume":"16","author":"N KFaOFL","year":"2013","unstructured":"KFaOFL N. Understanding the results of multiple linear regression. Beyon Standardized Regression Coefficients Orginazational Research Methods. 2013;16(4):650\u201371.","journal-title":"Beyon Standardized Regression Coefficients Orginazational Research Methods"},{"key":"5770_CR28","unstructured":"Team RC. R: A language and environment for statistical computing. Vienna, Austria 2018 [Available from: \n                    https:\/\/www.R-project.org\/\n                    \n                  ."},{"key":"5770_CR29","unstructured":"Nimon K, Oswald F, Roberts JK. Yhat: Interpreting Regression Effects 2013 [Available from: \n                    http:\/\/www.r-project.org\n                    \n                  ."},{"issue":"2","key":"5770_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/0029-7844(94)00383-O","volume":"85","author":"D Grady","year":"1995","unstructured":"Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol. 1995;85(2):304\u201313.","journal-title":"Obstet Gynecol"},{"issue":"6667","key":"5770_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/bmj.298.6667.147","volume":"298","author":"I Persson","year":"1989","unstructured":"Persson I, Adami HO, Bergkvist L, Lindgren A, Pettersson B, Hoover R, et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. BMJ (Clinical research ed). 1989;298(6667):147\u201351.","journal-title":"BMJ"},{"issue":"9484","key":"5770_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet (London, England). 2005;366(9484):491\u2013505.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"5770_CR33","doi-asserted-by":"publisher","first-page":"E330","DOI":"10.1210\/jc.2010-2050","volume":"96","author":"E Audet-Walsh","year":"2011","unstructured":"Audet-Walsh E, Lepine J, Gregoire J, Plante M, Caron P, Tetu B, et al. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab. 2011;96(2):E330\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5770_CR34","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1210\/jc.2013-2605","volume":"98","author":"F Wang","year":"2013","unstructured":"Wang F, Vihma V, Soronen J, Turpeinen U, Hamalainen E, Savolainen-Peltonen H, et al. 17beta-estradiol and estradiol fatty acyl esters and estrogen-converting enzyme expression in adipose tissue in obese men and women. J Clin Endocrinol Metab. 2013;98(12):4923\u201331.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"5770_CR35","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/15384047.2017.1394547","volume":"18","author":"W Tian","year":"2017","unstructured":"Tian W, Teng F, Zhao J, Gao J, Gao C, Sun D, et al. Estrogen and insulin synergistically promote type 1 endometrial cancer progression. Cancer Biol Ther. 2017;18(12):1000\u201310.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"5770_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10552-016-0751-4","volume":"27","author":"MA Merritt","year":"2016","unstructured":"Merritt MA, Strickler HD, Einstein MH, Yang HP, Sherman ME, Wentzensen N, et al. Insulin\/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors. Cancer Causes Control. 2016;27(6):737\u201348.","journal-title":"Cancer Causes Control"},{"issue":"8","key":"5770_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.tem.2006.08.006","volume":"17","author":"AG Renehan","year":"2006","unstructured":"Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17(8):328\u201336.","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"5770_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nrc3215","volume":"12","author":"M Pollak","year":"2012","unstructured":"Pollak M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer. 2012;12(3):159\u201369.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"5770_CR39","first-page":"3119","volume":"19","author":"EJ Crosbie","year":"2010","unstructured":"Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 2010;19(12):3119\u201330.","journal-title":"Oncology."},{"issue":"10","key":"5770_CR40","first-page":"963","volume":"10","author":"ME Sherman","year":"1997","unstructured":"Sherman ME, Sturgeon S, Brinton LA, Potischman N, Kurman RJ, Berman ML, et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol. 1997;10(10):963\u20138.","journal-title":"Mod Pathol"},{"issue":"2","key":"5770_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ijc.22260","volume":"120","author":"T Bjorge","year":"2007","unstructured":"Bjorge T, Engeland A, Tretli S, Weiderpass E. Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer. 2007;120(2):378\u201383.","journal-title":"Int J Cancer"},{"issue":"7","key":"5770_CR42","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1373\/clinchem.2016.258897","volume":"62","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, Bruckert E, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration Cutpoints-a joint consensus statement from the European atherosclerosis society and European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2016;62(7):930\u201346.","journal-title":"Clin Chem"},{"issue":"5","key":"5770_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/BF03350695","volume":"13","author":"S Panico","year":"1990","unstructured":"Panico S, Pisani P, Muti P, Recchione C, Cavalleri A, Totis A, et al. Diurnal variation of testosterone and estradiol: a source of bias in comparative studies on breast cancer. J Endocrinol Investig. 1990;13(5):423\u20136.","journal-title":"J Endocrinol Investig"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5770-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5770-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:11:57Z","timestamp":1591398717000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5770-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,7]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5770"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5770-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,7]]},"assertion":[{"value":"3 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki and was approved by the Local Ethical Committee of Radboud university medical center (2017\u20133251) on 21st of February 2017. All patients gave written informed consent for use of clinical data and tissue before entry in the Radboudumc biobank.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"547"}}